carbapenems has been researched along with me1036 in 9 studies
| Studies (carbapenems) | Trials (carbapenems) | Recent Studies (post-2010) (carbapenems) | Studies (me1036) | Trials (me1036) | Recent Studies (post-2010) (me1036) |
|---|---|---|---|---|---|
| 7,355 | 147 | 5,277 | 11 | 0 | 1 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 8 (88.89) | 29.6817 |
| 2010's | 1 (11.11) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hirai, Y; Ida, T; Kurazono, M; Maruyama, T; Shitara, E; Yamada, K; Yonezawa, M | 1 |
| Hirai, Y; Kijima, K; Kurazono, M; Nagura, J; Shitara, E; Sugano, T; Takahata, S; Takayama, Y; Tanaka, Y; Yamada, K; Yonezawa, M | 1 |
| Dalziel, C; Turner, B | 1 |
| Fritsche, TR; Jones, RN; Sader, HS | 1 |
| Hesek, D; Lee, M; Mobashery, S; Vakulenko, SB; Villegas-Estrada, A | 1 |
| Aguilar, L; Biek, D; Fenoll, A; Giménez, MJ; Granizo, JJ; Robledo, O; Tarragó, D | 1 |
| Izumikawa, K; Kakeya, H; Kamihira, S; Kohno, S; Kurihara, S; Morinaga, Y; Nakamura, S; Ohnishi, Y; Seki, M; Yamada, Y; Yamamoto, Y; Yanagihara, K | 1 |
| Biek, D; Janes, R; Morrissey, I | 1 |
| Hirai, Y; Ida, T; Maebashi, K; Takahata, S; Yamada, K | 1 |
9 other study(ies) available for carbapenems and me1036
| Article | Year |
|---|---|
In vitro activities of ME1036 (CP5609), a novel parenteral carbapenem, against methicillin-resistant staphylococci.
Topics: Bacterial Proteins; Carbapenems; Carrier Proteins; Electrophoretic Mobility Shift Assay; Gram-Negative Bacteria; Gram-Positive Bacteria; Hexosyltransferases; Methicillin Resistance; Microbial Sensitivity Tests; Muramoylpentapeptide Carboxypeptidase; Penicillin-Binding Proteins; Peptidyl Transferases; Plasmids; Staphylococcus aureus | 2004 |
Therapeutic effect of ME1036 on endocarditis experimentally induced by methicillin-resistant Staphylococcus aureus.
Topics: Animals; Anti-Bacterial Agents; Carbapenems; Colony Count, Microbial; Disease Models, Animal; Endocarditis, Bacterial; Female; Humans; Methicillin Resistance; Microbial Sensitivity Tests; Rabbits; Staphylococcal Infections; Staphylococcus aureus; Treatment Outcome; Vancomycin | 2005 |
Interscience conference on antimicrobial agents and chemotherapy--46th annual meeting. Release of data for Dc-159a, and other agents. 27-30 September 2006, San Francisco, CA, USA.
Topics: Animals; Anti-Infective Agents; Carbapenems; Cephalosporins; Drugs, Investigational; Estrogen Receptor Modulators; Fluoroquinolones; Humans; Naphthols; Societies, Scientific; United States | 2006 |
Antimicrobial activities of Ceftaroline and ME1036 tested against clinical strains of community-acquired methicillin-resistant Staphylococcus aureus.
Topics: Anti-Bacterial Agents; beta-Lactams; Carbapenems; Ceftaroline; Cephalosporins; Community-Acquired Infections; Humans; Methicillin Resistance; Microbial Sensitivity Tests; Staphylococcal Infections; Staphylococcus aureus; United States | 2008 |
Co-opting the cell wall in fighting methicillin-resistant Staphylococcus aureus: potent inhibition of PBP 2a by two anti-MRSA beta-lactam antibiotics.
Topics: Acetylglucosamine; Anti-Bacterial Agents; Binding Sites; Biomimetic Materials; Carbapenems; Ceftaroline; Cell Wall; Cephalosporins; Circular Dichroism; Kinetics; Methicillin Resistance; Muramic Acids; Penicillin-Binding Proteins; Peptide Synthases; Peptidoglycan; Protein Conformation; Staphylococcus aureus | 2008 |
In vitro activity of ME1036 versus other beta-lactams against penicillin-resistant Streptococcus pneumoniae serotypes exhibiting higher amoxicillin than penicillin MIC.
Topics: Amoxicillin; Anti-Bacterial Agents; Carbapenems; Humans; Microbial Sensitivity Tests; Penicillins; Pneumococcal Infections; Spain; Streptococcus pneumoniae | 2008 |
Efficacy of ME1036 against meticillin-resistant Staphylococcus aureus and vancomycin-insensitive S. aureus in a model of haematogenous pulmonary infection.
Topics: Animals; Anti-Bacterial Agents; Blood-Borne Pathogens; Carbapenems; Lung; Methicillin-Resistant Staphylococcus aureus; Mice; Pneumonia, Staphylococcal; Staphylococcus aureus; Tissue Distribution; Vancomycin; Vancomycin Resistance | 2008 |
ME1036, a novel carbapenem, with enhanced activity against clinical isolates causing bacteraemic community-acquired pneumonia.
Topics: Anti-Bacterial Agents; Bacteremia; Bacteria; Carbapenems; Community-Acquired Infections; Humans; Microbial Sensitivity Tests; Pneumonia, Bacterial | 2009 |
Correlation of the antimicrobial activity of ME1036 with its binding affinities to the penicillin-binding proteins from Streptococcus pneumoniae strains.
Topics: Anti-Bacterial Agents; Carbapenems; Colony Count, Microbial; Humans; Inhibitory Concentration 50; Microbial Viability; Models, Molecular; Molecular Structure; Penicillin-Binding Proteins; Protein Binding; Streptococcus pneumoniae | 2011 |